ArticleThe Journal of clinical investigation2026

Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma.

Raymond Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.